0
SHANGHAI, Nov 12 (Reuters) – China has approved Eli Lilly's weight loss pill orforglipron, the country's medicine regulator said on Thursday. (Reporting by Andrew Silver; additional reporting from
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
